Recently, two new services - ＂Day Ward＂ and ＂Consultation Center of Intractable Pain Cases＂ - were launched in Wuhan Tongji Cancer Center, in order to simplify diagnosis and treatment process, and improve patients...Recently, two new services - ＂Day Ward＂ and ＂Consultation Center of Intractable Pain Cases＂ - were launched in Wuhan Tongji Cancer Center, in order to simplify diagnosis and treatment process, and improve patients＇ quality life,展开更多
The 2014 Multidisciplinary Symposium for The Consultation Center of Intractable Pain Cases was held on April 21th, 2014. Fourteen departments took part in the symposium.
The 17th National Tumor Prophylaxis and Treatment Week, with the theme of "fight cancer scientifically and care life", kicked off in Wuhan, China. As one of the most important social works all over the year,...The 17th National Tumor Prophylaxis and Treatment Week, with the theme of "fight cancer scientifically and care life", kicked off in Wuhan, China. As one of the most important social works all over the year, the Week was broadened into a series of activities, lasting for one month, in Tongji Cancer Center, Tongji Hospital, Wu-han, China.展开更多
On February 2nd, World Cancer Day 2013 in China hosted by China Anti-Cancer Association （CACA）, and jointly undertaken by Cancer Rehabilitation and Palliative Care Committee, China （CRPC）, a branch of CACA,
The 3rd Session of PICC Concern Group in Tongji Cancer Center was held in the classroom of Tongji Cancer Center on April 17th, 2013. PICC （peripherally inserted central catheter） is a new technique which is widely a...The 3rd Session of PICC Concern Group in Tongji Cancer Center was held in the classroom of Tongji Cancer Center on April 17th, 2013. PICC （peripherally inserted central catheter） is a new technique which is widely adopted in Chinese hospitals soon after it was invented. The technique need smooth cooperation of medical staff and patients.展开更多
On April 12th, the 5th ＂Heart Warming＂ ＆ National Tumor Prophylaxis and Treatment Week Party was held in the classroom of Tongji Cancer Center by Tongji Cancer Center and ＂Sunshine Medical Students＂ group of Tong...On April 12th, the 5th ＂Heart Warming＂ ＆ National Tumor Prophylaxis and Treatment Week Party was held in the classroom of Tongji Cancer Center by Tongji Cancer Center and ＂Sunshine Medical Students＂ group of Tongji Young Volunteers Association. More than 100 patients and their care-givers enjoyed themselves in the party.展开更多
The intricate interplay between the human immune system and cancer development underscores the central role of immunotherapy in cancer treatment.Within this landscape,the innate immune system,a critical sentinel prote...The intricate interplay between the human immune system and cancer development underscores the central role of immunotherapy in cancer treatment.Within this landscape,the innate immune system,a critical sentinel protecting against tumor incursion,is a key player.The cyclic GMP-AMP synthase(c GAS)and stimulator of interferon genes(STING)pathway has been found to be a linchpin of innate immunity:activation of this signaling pathway orchestrates the production of type I interferon(IFN-α/β),thus fostering the maturation,differentiation,and mobilization of immune effectors in the tumor microenvironment.Furthermore,STING activation facilitates the release and presentation of tumor antigens,and therefore is an attractive target for cancer immunotherapy.Current strategies to activate the STING pathway,including use of pharmacological agonists,have made substantial advancements,particularly when combined with immune checkpoint inhibitors.These approaches have shown promise in preclinical and clinical settings,by enhancing patient survival rates.This review describes the evolving understanding of the c GAS-STING pathway's involvement in tumor biology and therapy.Moreover,this review explores classical and non-classical STING agonists,providing insights into their mechanisms of action and potential for optimizing immunotherapy strategies.Despite challenges and complexities,the c GAS-STING pathway,a promising avenue for enhancing cancer treatment efficacy,has the potential to revolutionize patient outcomes.展开更多
Gastric cancer(GC)is a major cause of cancer-related mortality worldwide.GC is determined by multiple(epi)genetic and environmental factors;can occur at distinct anatomic positions of the stomach;and displays high het...Gastric cancer(GC)is a major cause of cancer-related mortality worldwide.GC is determined by multiple(epi)genetic and environmental factors;can occur at distinct anatomic positions of the stomach;and displays high heterogeneity,with different cellular origins and diverse histological and molecular features.This heterogeneity has hindered efforts to fully understand the pathology of GC and develop efficient therapeutics.In the past decade,great progress has been made in the study of GC,particularly in molecular subtyping,investigation of the immune microenvironment,and defining the evolutionary path and dynamics.Preclinical mouse models,particularly immunocompetent models that mimic the cellular and molecular features of human GC,in combination with organoid culture and clinical studies,have provided powerful tools for elucidating the molecular and cellular mechanisms underlying GC pathology and immune evasion,and the development of novel therapeutic strategies.Herein,we first briefly introduce current progress and challenges in GC study and subsequently summarize immunocompetent GC mouse models,emphasizing the potential application of genetically engineered mouse models in antitumor immunity and immunotherapy studies.展开更多
Stroke,particularly ischemic stroke,is the leading cause of long-term disability and mortality worldwide.It occurs due to the occlusion of the cerebral arteries,which significantly reduces the delivery of blood,oxygen...Stroke,particularly ischemic stroke,is the leading cause of long-term disability and mortality worldwide.It occurs due to the occlusion of the cerebral arteries,which significantly reduces the delivery of blood,oxygen,and essential nutrients to brain tissues.This deprivation triggers a cascade of cellular events that ultimately leads to neuronal death.Recent studies have clarified the multifactorial pathogenesis of ischemic stroke,highlighting the roles of energy failure,excitotoxicity,oxidative stress,neuroinflammation,and apoptosis.This review aimed to provide a comprehensive insight into the fundamental mechanisms driving neuronal death triggered by ischemia and to examine the progress of neuroprotective therapeutic approaches designed to mitigate neuronal loss and promote neurological recovery after a stroke.Additionally,we explored widely accepted findings regarding the potential pathways implicated in neuronal death during ischemic stroke,including the interplay of apoptosis,autophagy,pyroptosis,ferroptosis,and necrosis,which collectively influence neuronal fate.We also discussed advancements in neuroprotective therapeutics,encompassing a range of interventions from pharmacological modulation to stem cell-based therapies,aimed at reducing neuronal injury and enhancing functional recovery following ischemic stroke.Despite these advancements,challenges remain in translating mechanistic insights into effective clinical therapies.Although neuroprotective strategies have shown promise in preclinical models,their efficacy in human trials has been inconsistent,often due to the complex pathology of ischemic stroke and the timing of interventions.In conclusion,this review synthesizes mechanistic insights into the intricate interplay of molecular and cellular pathways driving neuronal death post-ischemia.It sheds light on cutting-edge advancements in potential neuroprotective therapeutics,underscores the promise of regenerative medicine,and offers a forward-looking perspective on potential clinical breakthroughs.The ongoing evolution of precision-targeted interventions is expected to significantly enhance preventative strategies and improve clinical outcomes.展开更多
The tumor immune microenvironment(TIME)represents a complex battlefield where metabolic competition and immune evasion mechanisms converge to drive cancer progression.Amino acids,with their multifaceted biological rol...The tumor immune microenvironment(TIME)represents a complex battlefield where metabolic competition and immune evasion mechanisms converge to drive cancer progression.Amino acids,with their multifaceted biological roles,have emerged as pivotal regulators of tumor cell proliferation and immune cell functionality.The sensing mechanisms by which amino acids within the tumor microenvironment influence cellular growth,survival,and immune function are systematically explored in this review;the latest advances in understanding amino acid metabolism in tumor biology are also reviewed.In addition,the multifaceted roles of key amino acids in shaping the TIME with particular emphasis on tumor immunity and malignant growth were investigated.Finally,emerging therapeutic strategies targeting amino acid metabolism to reprogram the TIME are discussed,highlighting promising approaches,such as CAR-T cell therapy and engineered bacterial interventions.Through this comprehensive analysis,critical insights into future research directions and potential clinical translation of amino acid-targeted interventions are provided.展开更多
From Nov. 25th-27th, 2011, the 7th Conference of Chinese Cancer Rehabilitation and Palliative Care was held in Fuzhou, China. The conference focused on the patients＇ quality of life, and the methods to improve their ...From Nov. 25th-27th, 2011, the 7th Conference of Chinese Cancer Rehabilitation and Palliative Care was held in Fuzhou, China. The conference focused on the patients＇ quality of life, and the methods to improve their survival. The comprehensive therapy should be considered at the beginning of the treatment, and the treatment of rehabilitation and palliative care should be pursued throughout all the anti-cancer therapeutic process.展开更多
Obesity is one of the most serious global health problems,with an incidence that increases yearly and coincides with the development of cancer.Adipose tissue macrophages(ATMs)are particularly important in this context...Obesity is one of the most serious global health problems,with an incidence that increases yearly and coincides with the development of cancer.Adipose tissue macrophages(ATMs)are particularly important in this context and contribute to linking obesity-related inflammation and tumor progression.However,the functions of ATMs on the progression of obesity-associated cancer remain unclear.In this review,we describe the origins,phenotypes,and functions of ATMs.Subsequently,we summarize the potential mechanisms on the reprogramming of ATMs in the obesity-associated microenvironment,including the direct exchange of dysfunctional metabolites,inordinate cytokines and other signaling mediators,transfer of extracellular vesicle cargo,and variations in the gut microbiota and its metabolites.A better understanding of the properties and functions of ATMs under conditions of obesity will lead to the development of new therapeutic interventions for obesity-related cancer.展开更多
2013 National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China (CRPC) and European Association for Palliative Care (EAPC), was held on May ...2013 National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China (CRPC) and European Association for Palliative Care (EAPC), was held on May 18th–19th in Wuhan, China.More than 70 medical staff from 70 hospitals all over the country took part in the class.More than 10 specialists from home and abroad gave speeches on pain, digestive symptoms, respiratory symptoms, spiritual symptoms and end-of-life care.The training class was hosted by Professor Shiying Yu, chairmen of CPRC and chief of Tongji Cancer Center, and Professor Duanqi Liu, chief of Cancer Center, the General Hospital of Beijing Military Region (Fig.1).展开更多
The second session of 2013 National Cancer Special- ist Palliative Care Training Class, jointly hosted by Can- cer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliative C...The second session of 2013 National Cancer Special- ist Palliative Care Training Class, jointly hosted by Can- cer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliative Care （EAPC）, was held on July 20th-21th in Beijing. More than 60 medical staffs all over the country took part in the class. More than 10 specialists from home and abroad gave speeches on pain, digestive symptoms, respiratory symptoms, spiritual symptoms and end-of-life care.展开更多
The Tenth National Cancer Rehabilitation and Pal- liative Care Conference, with the theme of ＂Integrating Standardized Palliative Care throughout Anti-cancer Treatment＂, was successfully held on June 20th-22nd, 2014...The Tenth National Cancer Rehabilitation and Pal- liative Care Conference, with the theme of ＂Integrating Standardized Palliative Care throughout Anti-cancer Treatment＂, was successfully held on June 20th-22nd, 2014, in Shanghai. This conference was hosted by Can- cer Rehabilitation and Palliative Care Committee, China （CRPC）, jointly undertaken by Shanghai Anti-Cancer As- sociation and Shanghai Changzheng Hospital, and joint- ly supported by Chinese Society of Clinical Oncology （CSCO）, Shanghai Cancer Rehabilitation and Palliative Care Committee, Journey of＂Chinese Clinical Oncology＂ and Cancer Committee of Shanghai Medical Association. More than 1,500 medical staff attended the conference. The opening ceremony was held on June 21st. It was hosted by Professor Li Zhang, Director of Sun Yat-Sen University Cancer Center.展开更多
The first speech of CSCO-Lilly medical experts＇ auditorium in the year of 2011 was given on February 15th in Wuhan. Professor Shiying Yu, the chief of Tongji Cancer Center, and chairman of CRPC,
On Dec. 9th, 2011, the 2011 Symposium of Cancer Re- habilitation and Palliative Care Committee, Hubei was held in Wuhan, China. The symposium was hosted by Cancer Rehabilitation and Palliative Care Committee, Hubei, a...On Dec. 9th, 2011, the 2011 Symposium of Cancer Re- habilitation and Palliative Care Committee, Hubei was held in Wuhan, China. The symposium was hosted by Cancer Rehabilitation and Palliative Care Committee, Hubei, and jointly undertaken by Tongji Hospital, China. More than 100 cancer experts, clinicians and nurses participated in the conference. Professor Yuan Chen, from Tongji Cancer Center, Tongji Hospital, China, was elected as the new chairmen of Cancer Rehabilitation and Palliative Care Committee, Hubei, China.展开更多
The Chinese Anti-cancer Association launched the 16th National Tumor Prophylaxis and Treatment Week in April, 2010. In order to highlight the week＇s spirit of ＂Love life, scientific anti-cancer, better life＂, the T...The Chinese Anti-cancer Association launched the 16th National Tumor Prophylaxis and Treatment Week in April, 2010. In order to highlight the week＇s spirit of ＂Love life, scientific anti-cancer, better life＂, the Tongji Cancer Center and Thoracic Surgery Department held lectures and advisory services in the outpatient lobby of Cancer Center on April 20th, 2010. The content of lectures involves the prophylaxis, diagnosis and treatment of lung cancer,展开更多
Four sessions of the 2014 ＂SMILE＂ National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliat...Four sessions of the 2014 ＂SMILE＂ National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliative Care （EAPC）, supported by Xian-Janssen Pharmaceutical Ltd., was successfully held, including March 8th in Suzhou, March 22nd in Guangzhou, April 12th in Chengdu and April 26th in Wuhan. More than 200 medical staff all over the country took part in the class.展开更多
文摘Recently, two new services - ＂Day Ward＂ and ＂Consultation Center of Intractable Pain Cases＂ - were launched in Wuhan Tongji Cancer Center, in order to simplify diagnosis and treatment process, and improve patients＇ quality life,
文摘The 2014 Multidisciplinary Symposium for The Consultation Center of Intractable Pain Cases was held on April 21th, 2014. Fourteen departments took part in the symposium.
文摘The 17th National Tumor Prophylaxis and Treatment Week, with the theme of "fight cancer scientifically and care life", kicked off in Wuhan, China. As one of the most important social works all over the year, the Week was broadened into a series of activities, lasting for one month, in Tongji Cancer Center, Tongji Hospital, Wu-han, China.
文摘On February 2nd, World Cancer Day 2013 in China hosted by China Anti-Cancer Association （CACA）, and jointly undertaken by Cancer Rehabilitation and Palliative Care Committee, China （CRPC）, a branch of CACA,
文摘The 3rd Session of PICC Concern Group in Tongji Cancer Center was held in the classroom of Tongji Cancer Center on April 17th, 2013. PICC （peripherally inserted central catheter） is a new technique which is widely adopted in Chinese hospitals soon after it was invented. The technique need smooth cooperation of medical staff and patients.
文摘On April 12th, the 5th ＂Heart Warming＂ ＆ National Tumor Prophylaxis and Treatment Week Party was held in the classroom of Tongji Cancer Center by Tongji Cancer Center and ＂Sunshine Medical Students＂ group of Tongji Young Volunteers Association. More than 100 patients and their care-givers enjoyed themselves in the party.
基金the National Key Research and Development Program of China(Grant Nos.2022YFC3401500 and 2020YFA0803201 to P.W.,and 2021YFA1302200 to L.F.)the National Natural Science Foundation of China(Grant Nos.31830053,31920103007,and 82341028 to P.W.+1 种基金82122056,82073153,and 31871398 to L.F.and 31900568 to P.W.)the Natural Science Foundation of Shanghai(Grant No.22ZR1450700 to Z.J.W.)。
文摘The intricate interplay between the human immune system and cancer development underscores the central role of immunotherapy in cancer treatment.Within this landscape,the innate immune system,a critical sentinel protecting against tumor incursion,is a key player.The cyclic GMP-AMP synthase(c GAS)and stimulator of interferon genes(STING)pathway has been found to be a linchpin of innate immunity:activation of this signaling pathway orchestrates the production of type I interferon(IFN-α/β),thus fostering the maturation,differentiation,and mobilization of immune effectors in the tumor microenvironment.Furthermore,STING activation facilitates the release and presentation of tumor antigens,and therefore is an attractive target for cancer immunotherapy.Current strategies to activate the STING pathway,including use of pharmacological agonists,have made substantial advancements,particularly when combined with immune checkpoint inhibitors.These approaches have shown promise in preclinical and clinical settings,by enhancing patient survival rates.This review describes the evolving understanding of the c GAS-STING pathway's involvement in tumor biology and therapy.Moreover,this review explores classical and non-classical STING agonists,providing insights into their mechanisms of action and potential for optimizing immunotherapy strategies.Despite challenges and complexities,the c GAS-STING pathway,a promising avenue for enhancing cancer treatment efficacy,has the potential to revolutionize patient outcomes.
基金supported by the National Key R&D Program of China(Grant No.2020YFA0803200 and 2023YFC2505903)National Natural Science Foundation of China(Grant Nos.82003014,31930026,81972876,82150112,92168116,81725014,81822035,and 82222052)+1 种基金China Postdoctoral Science Foundation(Grant No.2020M671231)Fundamental Research Funds for the Central Universities(Grant No.22120240327)。
文摘Gastric cancer(GC)is a major cause of cancer-related mortality worldwide.GC is determined by multiple(epi)genetic and environmental factors;can occur at distinct anatomic positions of the stomach;and displays high heterogeneity,with different cellular origins and diverse histological and molecular features.This heterogeneity has hindered efforts to fully understand the pathology of GC and develop efficient therapeutics.In the past decade,great progress has been made in the study of GC,particularly in molecular subtyping,investigation of the immune microenvironment,and defining the evolutionary path and dynamics.Preclinical mouse models,particularly immunocompetent models that mimic the cellular and molecular features of human GC,in combination with organoid culture and clinical studies,have provided powerful tools for elucidating the molecular and cellular mechanisms underlying GC pathology and immune evasion,and the development of novel therapeutic strategies.Herein,we first briefly introduce current progress and challenges in GC study and subsequently summarize immunocompetent GC mouse models,emphasizing the potential application of genetically engineered mouse models in antitumor immunity and immunotherapy studies.
基金supported by the National Natural Science Foundation of China,Nos.82171387 and 31830111(both to SL).
文摘Stroke,particularly ischemic stroke,is the leading cause of long-term disability and mortality worldwide.It occurs due to the occlusion of the cerebral arteries,which significantly reduces the delivery of blood,oxygen,and essential nutrients to brain tissues.This deprivation triggers a cascade of cellular events that ultimately leads to neuronal death.Recent studies have clarified the multifactorial pathogenesis of ischemic stroke,highlighting the roles of energy failure,excitotoxicity,oxidative stress,neuroinflammation,and apoptosis.This review aimed to provide a comprehensive insight into the fundamental mechanisms driving neuronal death triggered by ischemia and to examine the progress of neuroprotective therapeutic approaches designed to mitigate neuronal loss and promote neurological recovery after a stroke.Additionally,we explored widely accepted findings regarding the potential pathways implicated in neuronal death during ischemic stroke,including the interplay of apoptosis,autophagy,pyroptosis,ferroptosis,and necrosis,which collectively influence neuronal fate.We also discussed advancements in neuroprotective therapeutics,encompassing a range of interventions from pharmacological modulation to stem cell-based therapies,aimed at reducing neuronal injury and enhancing functional recovery following ischemic stroke.Despite these advancements,challenges remain in translating mechanistic insights into effective clinical therapies.Although neuroprotective strategies have shown promise in preclinical models,their efficacy in human trials has been inconsistent,often due to the complex pathology of ischemic stroke and the timing of interventions.In conclusion,this review synthesizes mechanistic insights into the intricate interplay of molecular and cellular pathways driving neuronal death post-ischemia.It sheds light on cutting-edge advancements in potential neuroprotective therapeutics,underscores the promise of regenerative medicine,and offers a forward-looking perspective on potential clinical breakthroughs.The ongoing evolution of precision-targeted interventions is expected to significantly enhance preventative strategies and improve clinical outcomes.
基金supported by grants from the National Key Research and Development Program of China(Grant No.2022YFC3401500 to P.W.Grant No.2021YFA1302200 to L.F.)+1 种基金the National Natural Science Foundation of China(Grant Nos.82341028 and 31920103007 to P.W.Grant Nos.82472815 and U24A20727 to L.F.)。
文摘The tumor immune microenvironment(TIME)represents a complex battlefield where metabolic competition and immune evasion mechanisms converge to drive cancer progression.Amino acids,with their multifaceted biological roles,have emerged as pivotal regulators of tumor cell proliferation and immune cell functionality.The sensing mechanisms by which amino acids within the tumor microenvironment influence cellular growth,survival,and immune function are systematically explored in this review;the latest advances in understanding amino acid metabolism in tumor biology are also reviewed.In addition,the multifaceted roles of key amino acids in shaping the TIME with particular emphasis on tumor immunity and malignant growth were investigated.Finally,emerging therapeutic strategies targeting amino acid metabolism to reprogram the TIME are discussed,highlighting promising approaches,such as CAR-T cell therapy and engineered bacterial interventions.Through this comprehensive analysis,critical insights into future research directions and potential clinical translation of amino acid-targeted interventions are provided.
文摘From Nov. 25th-27th, 2011, the 7th Conference of Chinese Cancer Rehabilitation and Palliative Care was held in Fuzhou, China. The conference focused on the patients＇ quality of life, and the methods to improve their survival. The comprehensive therapy should be considered at the beginning of the treatment, and the treatment of rehabilitation and palliative care should be pursued throughout all the anti-cancer therapeutic process.
基金supported by the Fundamental Research Funds for the Central Universities(2042021kf0102,2042021kf0083)supported by two National Natural Science Foundation of China(NSFC)Grants(81903166,82203629)+1 种基金a Natural Science Foundation of Hubei(2018CKB916)sponsored by Shanghai Pujiang Program(22PJD054).
文摘Obesity is one of the most serious global health problems,with an incidence that increases yearly and coincides with the development of cancer.Adipose tissue macrophages(ATMs)are particularly important in this context and contribute to linking obesity-related inflammation and tumor progression.However,the functions of ATMs on the progression of obesity-associated cancer remain unclear.In this review,we describe the origins,phenotypes,and functions of ATMs.Subsequently,we summarize the potential mechanisms on the reprogramming of ATMs in the obesity-associated microenvironment,including the direct exchange of dysfunctional metabolites,inordinate cytokines and other signaling mediators,transfer of extracellular vesicle cargo,and variations in the gut microbiota and its metabolites.A better understanding of the properties and functions of ATMs under conditions of obesity will lead to the development of new therapeutic interventions for obesity-related cancer.
文摘2013 National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China (CRPC) and European Association for Palliative Care (EAPC), was held on May 18th–19th in Wuhan, China.More than 70 medical staff from 70 hospitals all over the country took part in the class.More than 10 specialists from home and abroad gave speeches on pain, digestive symptoms, respiratory symptoms, spiritual symptoms and end-of-life care.The training class was hosted by Professor Shiying Yu, chairmen of CPRC and chief of Tongji Cancer Center, and Professor Duanqi Liu, chief of Cancer Center, the General Hospital of Beijing Military Region (Fig.1).
文摘The second session of 2013 National Cancer Special- ist Palliative Care Training Class, jointly hosted by Can- cer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliative Care （EAPC）, was held on July 20th-21th in Beijing. More than 60 medical staffs all over the country took part in the class. More than 10 specialists from home and abroad gave speeches on pain, digestive symptoms, respiratory symptoms, spiritual symptoms and end-of-life care.
文摘The Tenth National Cancer Rehabilitation and Pal- liative Care Conference, with the theme of ＂Integrating Standardized Palliative Care throughout Anti-cancer Treatment＂, was successfully held on June 20th-22nd, 2014, in Shanghai. This conference was hosted by Can- cer Rehabilitation and Palliative Care Committee, China （CRPC）, jointly undertaken by Shanghai Anti-Cancer As- sociation and Shanghai Changzheng Hospital, and joint- ly supported by Chinese Society of Clinical Oncology （CSCO）, Shanghai Cancer Rehabilitation and Palliative Care Committee, Journey of＂Chinese Clinical Oncology＂ and Cancer Committee of Shanghai Medical Association. More than 1,500 medical staff attended the conference. The opening ceremony was held on June 21st. It was hosted by Professor Li Zhang, Director of Sun Yat-Sen University Cancer Center.
文摘The first speech of CSCO-Lilly medical experts＇ auditorium in the year of 2011 was given on February 15th in Wuhan. Professor Shiying Yu, the chief of Tongji Cancer Center, and chairman of CRPC,
文摘On Dec. 9th, 2011, the 2011 Symposium of Cancer Re- habilitation and Palliative Care Committee, Hubei was held in Wuhan, China. The symposium was hosted by Cancer Rehabilitation and Palliative Care Committee, Hubei, and jointly undertaken by Tongji Hospital, China. More than 100 cancer experts, clinicians and nurses participated in the conference. Professor Yuan Chen, from Tongji Cancer Center, Tongji Hospital, China, was elected as the new chairmen of Cancer Rehabilitation and Palliative Care Committee, Hubei, China.
文摘The Chinese Anti-cancer Association launched the 16th National Tumor Prophylaxis and Treatment Week in April, 2010. In order to highlight the week＇s spirit of ＂Love life, scientific anti-cancer, better life＂, the Tongji Cancer Center and Thoracic Surgery Department held lectures and advisory services in the outpatient lobby of Cancer Center on April 20th, 2010. The content of lectures involves the prophylaxis, diagnosis and treatment of lung cancer,
文摘Four sessions of the 2014 ＂SMILE＂ National Cancer Specialist Palliative Care Training Class, jointly hosted by Cancer Rehabilitation and Palliative Care Committee, China （CRPC） and European Association for Palliative Care （EAPC）, supported by Xian-Janssen Pharmaceutical Ltd., was successfully held, including March 8th in Suzhou, March 22nd in Guangzhou, April 12th in Chengdu and April 26th in Wuhan. More than 200 medical staff all over the country took part in the class.
